Literature DB >> 7575257

Ocular surface changes and discomfort in patients with meibomian gland dysfunction.

J Shimazaki1, M Sakata, K Tsubota.   

Abstract

OBJECTIVE: To determine the importance of meibomian gland dysfunction (MGD) on the ocular surface.
DESIGN: Prospective study.
SETTING: A university-based referral practice. PATIENTS: Patients with ocular discomfort (147 eyes) and without ocular discomfort (54 eyes) were examined. In the total 201 eyes, MGD was defined as the presence of an obstruction of the meibomian orifices (obstruction group [n = 54]) or the absence of a gland structure (gland dropout group [n = 36]), or both of these findings (combined group [n = 38]). There were not any findings of MGD in 73 eyes (non-MGD group). MAIN OUTCOME MEASURES: Scores that were obtained from fluorescein and rose bengal staining, the breakup time of the tear film, the rates of tear evaporation and tear production, and meibography.
RESULTS: Of the 147 eyes with ocular discomfort, 95 (64.6%) had either an obstruction of an orifice or gland dropout, or both. The combined group had higher scores for staining with fluorescein (P = .002) and rose bengal (P = .021) compared with that in the non-MGD group. The rate of tear production was increased more in the gland dropout group than in the non-MGD group (P = .002). The rate of tear evaporation was significantly increased in the gland dropout group (P = .017).
CONCLUSION: Meibomian gland dysfunction is a major cause of ocular surface abnormalities and ocular discomfort.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7575257     DOI: 10.1001/archopht.1995.01100100054027

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  107 in total

1.  The use of fluorescent quenching in studying the contribution of evaporation to tear thinning.

Authors:  Jason J Nichols; P Ewen King-Smith; Erich A Hinel; Miru Thangavelu; Kelly K Nichols
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-08-20       Impact factor: 4.799

2.  Efficacy of diagnostic criteria for the differential diagnosis between obstructive meibomian gland dysfunction and aqueous deficiency dry eye.

Authors:  Reiko Arita; Kouzo Itoh; Syuji Maeda; Koshi Maeda; Atsuo Tomidokoro; Shiro Amano
Journal:  Jpn J Ophthalmol       Date:  2010-11-05       Impact factor: 2.447

Review 3.  Interventions for chronic blepharitis.

Authors:  Kristina Lindsley; Sueko Matsumura; Elham Hatef; Esen K Akpek
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

4.  Culture, immortalization, and characterization of human meibomian gland epithelial cells.

Authors:  Shaohui Liu; Mark P Hatton; Payal Khandelwal; David A Sullivan
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-03-24       Impact factor: 4.799

Review 5.  Eye complaints in the office environment: precorneal tear film integrity influenced by eye blinking efficiency.

Authors:  P Wolkoff; J K Nøjgaard; P Troiano; B Piccoli
Journal:  Occup Environ Med       Date:  2005-01       Impact factor: 4.402

6.  The evaluation of the treatment response in obstructive meibomian gland disease by in vivo laser confocal microscopy.

Authors:  Yukihiro Matsumoto; Yuta Shigeno; Enrique Adan Sato; Osama M A Ibrahim; Megumi Saiki; Kazuno Negishi; Yoko Ogawa; Murat Dogru; Kazuo Tsubota
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-12-20       Impact factor: 3.117

7.  Meibography: A review of techniques and technologies.

Authors:  Ryan J Wise; Rachel K Sobel; Richard C Allen
Journal:  Saudi J Ophthalmol       Date:  2012-10

Review 8.  Meibocyte differentiation and renewal: Insights into novel mechanisms of meibomian gland dysfunction (MGD).

Authors:  Ho Sik Hwang; Geraint J Parfitt; Donald J Brown; James V Jester
Journal:  Exp Eye Res       Date:  2017-02-17       Impact factor: 3.467

9.  Lipidomic analysis of human tear fluid reveals structure-specific lipid alterations in dry eye syndrome.

Authors:  Sin Man Lam; Louis Tong; Bastien Reux; Xinrui Duan; Andrea Petznick; Siew Sian Yong; Cynthia Boo Shiao Khee; Martin J Lear; Markus R Wenk; Guanghou Shui
Journal:  J Lipid Res       Date:  2013-11-28       Impact factor: 5.922

10.  Reduced ocular surface disease index (OSDI) scores in patients with isotretinoin treatment.

Authors:  Cagatay Caglar; Engin Senel; Emine Sabancilar; Mustafa Durmus
Journal:  Int Ophthalmol       Date:  2016-05-18       Impact factor: 2.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.